In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) closed at $15.82 down -2.83% from its previous closing price of $16.28. In other words, the price has decreased by -$2.83 from its previous closing price. On the day, 0.79 million shares were traded. TNXP stock price reached its highest trading level at $17.23 during the session, while it also had its lowest trading level at $15.7515.
Ratios:
For a deeper understanding of Tonix Pharmaceuticals Holding Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.62 and its Current Ratio is at 9.89. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On April 18, 2019, ROTH Capital Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $4.
ROTH Capital Upgraded its Neutral to Buy on August 18, 2017, while the target price for the stock was maintained at $6.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 21 ’25 when Taylor Carolyn E. bought 418 shares for $36.03 per share. The transaction valued at 15,061 led to the insider holds 418 shares of the business.
Treco James bought 250 shares of TNXP for $9,000 on Aug 20 ’25. The Director now owns 250 shares after completing the transaction at $36.00 per share. On May 15 ’25, another insider, LEDERMAN SETH, who serves as the Chief Executive Officer of the company, bought 4,000 shares for $21.55 each. As a result, the insider paid 86,200 and bolstered with 4,005 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNXP now has a Market Capitalization of 186304896 and an Enterprise Value of -3325105. For the stock, the TTM Price-to-Sale (P/S) ratio is 18.09 while its Price-to-Book (P/B) ratio in mrq is 0.70. Its current Enterprise Value per Revenue stands at -0.323 whereas that against EBITDA is 0.034.
Stock Price History:
The Beta on a monthly basis for TNXP is 1.80, which has changed by -0.47483873 over the last 52 weeks, in comparison to a change of 0.17673707 over the same period for the S&P500. Over the past 52 weeks, TNXP has reached a high of $69.97, while it has fallen to a 52-week low of $6.76. The 50-Day Moving Average of the stock is -10.23%, while the 200-Day Moving Average is calculated to be -41.54%.
Shares Statistics:
For the past three months, TNXP has traded an average of 734.51K shares per day and 446910 over the past ten days. A total of 11.78M shares are outstanding, with a floating share count of 11.77M. Insiders hold about 0.04% of the company’s shares, while institutions hold 20.07% stake in the company. Shares short for TNXP as of 1765756800 were 2216942 with a Short Ratio of 3.02, compared to 1763078400 on 1944721. Therefore, it implies a Short% of Shares Outstanding of 2216942 and a Short% of Float of 18.83.
